Neoantigen Vaccines Pass the Immunogenicity Test

被引:35
|
作者
Linette, Gerald P. [1 ,2 ]
Carreno, Beatriz M. [2 ,3 ]
机构
[1] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Dept Hematol Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.molmed.2017.08.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neoantigens arising from tumor-specific genomic alterations constitute authentic non-self antigens and represent a new class of targets for cancer immunotherapy. Recent reports on various vaccine platforms targeting neoantigens suggest a basis for precision therapies customized to each patient's tumor mutational profile.
引用
收藏
页码:869 / 871
页数:3
相关论文
共 50 条
  • [21] Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
    Roerden, Malte
    Castro, Andrea B.
    Cui, Yufei
    Harake, Noora
    Kim, Byungji
    Dye, Jonathan
    Maiorino, Laura
    White, Forest M.
    Irvine, Darrell J.
    Litchfield, Kevin
    Spranger, Stefani
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [22] IMMUNOGENICITY OF CHOLERA VACCINES
    BHATIA, AL
    KAUR, J
    SHRIVASTAV, JB
    NATH, ML
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1964, 52 (08) : 831 - +
  • [23] Challenges in developing personalized neoantigen cancer vaccines
    Peter D. Katsikis
    Ken J. Ishii
    Christopher Schliehe
    Nature Reviews Immunology, 2024, 24 (3) : 213 - 227
  • [24] Neoantigen sequestrated autophagosomes as therapeutic cancer vaccines
    Zhang, Jinxie
    Cao, Jiahui
    Wang, Liuchang
    Li, Sitong
    Meng, Fanqiang
    Liang, Xin
    Jiang, Hanyu
    Luo, Ran
    Zhu, Dunwan
    Zhang, Fan
    Zhang, Linhua
    Zhang, Xudong
    Mei, Lin
    JOURNAL OF CONTROLLED RELEASE, 2024, 376 : 369 - 381
  • [25] Designing neoantigen cancer vaccines, trials, and outcomes
    Biswas, Nupur
    Chakrabarti, Shweta
    Padul, Vijay
    Jones, Lawrence D.
    Ashili, Shashaanka
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Neoantigen cancer vaccines: a new star on the horizon
    Xiaoling Li
    Jian You
    Liping Hong
    Weijiang Liu
    Peng Guo
    Xishan Hao
    Cancer Biology & Medicine, 2024, 21 (04) : 274 - 311
  • [27] IMMUNE RESPONSES TO PERSONALIZED NEOANTIGEN VACCINES ARE DURABLE
    不详
    CANCER DISCOVERY, 2021, 11 (03) : 531 - 531
  • [28] Challenges in developing personalized neoantigen cancer vaccines
    Katsikis, Peter D.
    Ishii, Ken J.
    Schliehe, Christopher
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (03) : 213 - 227
  • [29] Personal neoantigen cancer vaccines The momentum builds
    Fritsch, Edward F.
    Hacohen, Nir
    Wu, Catherine J.
    ONCOIMMUNOLOGY, 2014, 3 (06)
  • [30] Calling cancer's bluff with neoantigen vaccines
    DeWeerdt S.
    Nature, 2017, 552 (7685) : S76 - S77